Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer
Posted on 2020-11-12 - 04:44
Abstract One unmet challenge in lung cancer diagnosis is to accurately differentiate lung cancer from other lung diseases with similar clinical symptoms and radiological features, such as pulmonary tuberculosis (TB). To identify reliable biomarkers for lung cancer screening, we leverage the recently discovered non-canonical small non-coding RNAs (i.e., tRNA-derived small RNAs [tsRNAs], rRNA-derived small RNAs [rsRNAs], and YRNA-derived small RNAs [ysRNAs]) in human peripheral blood mononuclear cells and develop a molecular signature composed of distinct ts/rs/ysRNAs (TRY-RNA). Our TRY-RNA signature precisely discriminates between control, lung cancer, and pulmonary TB subjects in both the discovery and validation cohorts and outperforms microRNA-based biomarkers, which bears the diagnostic potential for lung cancer screening.
CITE THIS COLLECTION
Gu, Wanjun; Shi, Junchao; Liu, Hui; Zhang, Xudong; Zhou, Jin J.; Li, Musheng; et al. (2020): Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer. figshare. Collection. https://doi.org/10.6084/m9.figshare.c.5204837.v1
Select your citation style and then place your mouse over the citation text to select it.
Read the peer-reviewed publication
Jin J. Zhou
Kenneth S. Knox